2Suppliers
0Customers
3Debt Items
20Related Chains

Celcuity Inc. Suppliers

TickerNameConfidenceEvidence
PFE Pfizer Inc. 92% The Company entered into a license agreement with Pfizer to research, develop, manufacture and commercialize gedatolisib.
PFE Pfizer Inc. 92% Reciprocal relationship from PFE graph: Reciprocal relationship from CELC graph: The Company entered into a license agreement with Pfizer to research, develop, manufacture and commercialize gedatolisib.

Celcuity Inc. Customers

No clients on recordNo downstream customers found in our database for Celcuity Inc..

Celcuity Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CELC-DEBT-8579 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
CELC-DEBT-8578 Warrants outstanding: 1827357 90% xbrl warrant detail from xbrl 2025-12-31.
CELC-DEBT Debt stack $323.4M 90% Market cache reports total debt of $323.4M.

Celcuity Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Celcuity Inc..

Celcuity Inc. Ownership

HolderNameConfidenceEvidence
CELC-OWNER-BAKER-BROS-ADVISORS-LP BAKER BROS. ADVISORS LP 90% 13F overlay lists BAKER BROS. ADVISORS LP as top holder; 281 tracked holders.

Celcuity Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
PFE Pfizer Inc. 100.00 1 ['supplier']
CTMX CytomX Therapeutics, Inc. 50.00 2
CELG-RI BRISTOL MYERS SQUIBB CO 50.00 2
ORANY ORANGE 50.00 2
ALLO Allogene Therapeutics, Inc. 50.00 2
CAH Cardinal Health, Inc. 50.00 2
ARVN Arvinas, Inc. 50.00 2
RLAY Relay Therapeutics, Inc. 50.00 2
SPRO Spero Therapeutics, Inc. 50.00 2
HBIO Harvard Bioscience, Inc. 50.00 2
ESPR Esperion Therapeutics, Inc. 50.00 2
NVAX Novavax, Inc. 50.00 2
NRIX Nurix Therapeutics, Inc. 50.00 2
ITRM Iterum Therapeutics PLC 50.00 2
PYXS Pyxis Oncology, Inc. 50.00 2
OPK OPKO Health, Inc. 50.00 2
PLX Protalix BioTherapeutics, Inc. 50.00 2
ZLAB Zai Lab Limited 50.00 2
ZNTL Zentalis Pharmaceuticals, Inc. 50.00 2
AURX Nuo Therapeutics, Inc. 50.00 2